NCT05582837View on ClinicalTrials.gov

Treatment of Meniere's Disease With Migraine Medications

PHASE4RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2022

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions
Ménière
Interventions
DRUG

nortriptyline + topiramate

nortriptyline (7.5mg) + topiramate (10mg) taken 1x per day and escalate weekly as needed for 8 weeks

Trial Locations (1)

92868

RECRUITING

University of California, Irvine Medical Center ENT Clinic (Pavilion 2), Orange

All Listed Sponsors
lead

University of California, Irvine

OTHER